Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-EN Version v7-FR
Language English French
Date Updated 2017-12-05 2017-10-06
Drug Identification Number 02088401 02088401
Brand name MYLAN-BACLOFEN MYLAN-BACLOFEN
Common or Proper name BACLOFEN BACLOFEN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients BACLOFEN BACLOFEN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code M03BX M03BX
ATC description MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-11-20 2017-11-10
Actual start date 2017-10-17
Estimated end date 2017-12-22 2017-12-12
Actual end date 2017-12-04
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments